Abbott | ABT - Debt

Stock Price
114.76
Daily Change
0.18 0.16%
Monthly
5.51%
Yearly
-15.59%
Q1 Forecast
108.73

Abbott reported $12.94B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Agilent USD 3.35B 55M Sep/2025
AtriCure USD 76.73M 521K Sep/2025
Baxter International USD 9.71B 13M Sep/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Bio-Rad Laboratories USD 1.4B 11.2M Sep/2025
Boston Scientific USD 12.05B 19M Sep/2025
Cooper Companies USD 2.48B 285.1M Jun/2025
Danaher USD 18.42B 1.56B Dec/2025
Dexcom USD 1.24B 1.21B Dec/2025
Edwards Lifesciences USD 700.3M 2.3M Sep/2025
Globus Medical USD 119.34M 1.76M Sep/2025
Hologic USD 2.63B 104.3M Sep/2025
Insulet USD 1.01B 384.9M Sep/2025
Integra LifeSciences USD 2.01B 170.48M Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 45.8B 4.97B Sep/2025
Masimo USD 642.2M 299.4M Jun/2025
Medtronic USD 29.1B 491M Sep/2025
Merit Medical Systems USD 821.15M 599K Sep/2025
Pfizer USD 60.85B 78M Sep/2025
Smith & Nephew USD 3.32B 334M Dec/2024
Solventum Corp USD 7.91B 97M Mar/2025
Stryker USD 14.86B 1.74B Dec/2025
Tandem Diabetes Care USD 449.28M 276K Sep/2025
Teleflex USD 2B 180.08M Jun/2025
Terumo JPY 159.87B 14.97B Sep/2025
Thermo Fisher Scientific USD 35.68B 451M Sep/2025
Zimmer Biomet Holdings USD 7.52B 593.5M Dec/2025